Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10.

Mazzoccoli L, Cadoso SH, Amarante GW, de Souza MV, Domingues R, Machado MA, de Almeida MV, Teixeira HC.

Biomed Pharmacother. 2012 Jul;66(5):323-9. doi: 10.1016/j.biopha.2012.05.001. Epub 2012 Jun 15.

PMID:
22770990
2.

Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells.

Rowland TL, McHugh SM, Deighton J, Dearman RJ, Ewan PW, Kimber I.

Immunopharmacology. 1998 Jul;40(1):11-20.

PMID:
9776474
3.

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.

Corral LG, Haslett PA, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G.

J Immunol. 1999 Jul 1;163(1):380-6.

4.

Selective down-regulation of T cell- and non-T cell-derived tumour necrosis factor alpha by thalidomide: comparisons with dexamethasone.

Rowland TL, McHugh SM, Deighton J, Ewan PW, Dearman RJ, Kimber I.

Immunol Lett. 1999 Jun 1;68(2-3):325-32.

PMID:
10424439
5.

Thalidomide suppressed IL-1beta while enhancing TNF-alpha and IL-10, when cells in whole blood were stimulated with lipopolysaccharide.

Shannon E, Noveck R, Sandoval F, Kamath B.

Immunopharmacol Immunotoxicol. 2008;30(3):447-57. doi: 10.1080/08923970802135161 .

PMID:
18668392
6.

Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.

Schafer PH, Parton A, Gandhi AK, Capone L, Adams M, Wu L, Bartlett JB, Loveland MA, Gilhar A, Cheung YF, Baillie GS, Houslay MD, Man HW, Muller GW, Stirling DI.

Br J Pharmacol. 2010 Feb;159(4):842-55. doi: 10.1111/j.1476-5381.2009.00559.x. Epub 2009 Dec 24.

7.

Design, synthesis and biological evaluation of new thalidomide analogues as TNF-α and IL-6 production inhibitors.

Chaulet C, Croix C, Alagille D, Normand S, Delwail A, Favot L, Lecron JC, Viaud-Massuard MC.

Bioorg Med Chem Lett. 2011 Feb 1;21(3):1019-22. doi: 10.1016/j.bmcl.2010.12.031. Epub 2010 Dec 10.

PMID:
21215621
8.

Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.

Corral LG, Muller GW, Moreira AL, Chen Y, Wu M, Stirling D, Kaplan G.

Mol Med. 1996 Jul;2(4):506-15.

9.

Effects of compounds from bi-qi capsule on the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 macrophages.

Wang QS, Cui YL, Wang YF, Chi W.

J Ethnopharmacol. 2011 Jul 14;136(3):480-7. doi: 10.1016/j.jep.2010.06.008. Epub 2010 Jun 15.

PMID:
20558268
10.

Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity.

Zhu X, Giordano T, Yu QS, Holloway HW, Perry TA, Lahiri DK, Brossi A, Greig NH.

J Med Chem. 2003 Nov 20;46(24):5222-9.

PMID:
14613324
11.

Immunomodulatory drugs inhibit expression of cyclooxygenase-2 from TNF-alpha, IL-1beta, and LPS-stimulated human PBMC in a partially IL-10-dependent manner.

Payvandi F, Wu L, Haley M, Schafer PH, Zhang LH, Chen RS, Muller GW, Stirling DI.

Cell Immunol. 2004 Aug;230(2):81-8.

PMID:
15598423
12.

Tetomilast suppressed production of proinflammatory cytokines from human monocytes and ameliorated chronic colitis in IL-10-deficient mice.

Ichikawa H, Okamoto S, Kamada N, Nagamoto H, Kitazume MT, Kobayashi T, Chinen H, Hisamatsu T, Hibi T.

Inflamm Bowel Dis. 2008 Nov;14(11):1483-90. doi: 10.1002/ibd.20524.

PMID:
18618633
13.
14.
15.

Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.

Luna T, Santos SB, Nascimento M, Porto MA, Muniz AL, Carvalho EM, Jesus AR.

Braz J Med Biol Res. 2011 Nov;44(11):1134-40. Epub 2011 Oct 22.

16.

Immunomodulatory assays to study structure-activity relationships of thalidomide.

Shannon EJ, Morales MJ, Sandoval F.

Immunopharmacology. 1997 Jan;35(3):203-12.

PMID:
9043933
18.

Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12/IL-10 balance in human primary cells.

Melchjorsen J, Risør MW, Søgaard OS, O'Loughlin KL, Chow S, Paludan SR, Ellermann-Eriksen S, Hedley DW, Minderman H, Østergaard L, Tolstrup M.

J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):265-75. doi: 10.1097/QAI.0b013e3182185276.

PMID:
21471820
19.

Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.

Andersson J, Skansén-Saphir U, Sparrelid E, Andersson U.

Clin Exp Immunol. 1996 May;104 Suppl 1:10-20.

20.

In vivo and in vitro cytokine modulatory activity of newly synthesised 2-aminotetraline derivatives.

Ruggiero V, Piovesan P, Fabrizi C, Lauro GM, Campo S, Albertoni C, Nucera E, Carminati P, Ghirardi O.

Shock. 2004 Jan;21(1):77-85.

PMID:
14676688
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk